Prof. How-Ran Guo
Prof. How-Ran Guo
NationalCheng Kung University, Chinese Taipei


1994 Ph.D., Harvard University, Environmental Health
1988 Ph.D., Taipei Medical College, Medicine
1990 M.S., Harvard University, Epidemiology

1989 M.S., Harvard University, Public Health

Publications (Selected)
  1. Lu F-J, Guo H-R, Chiang H-S, Hong C-L. Relationships between the fluorescent intensity of well water and the incidence rate of bladder cancer. Journal of Chinese Oncology Society 2:14-23, 1986.
  2. Chiang H-S, Hong C-L, Guo H-R, Lee EF, Chen T-Y. Comparative study on the high prevalence of bladder cancer in the blackfoot disease endemic area in Taiwan. Journal of the Formosan Medical Association 87(11):1074-1080, Nov. 1988.
  3. Chiang H-S, Hong C-L, Guo H-R, Lin S-M, Lee E-F, Lee H-S. Report on endemic survey of bladder cancer in blackfoot disease area--Bladder cancer prevalence survey in the "high risk villages" of the black foot disease endemic area. Journal of Chinese Oncology Society 4:14-22, 1989.
  4. Jeng J-J, Kao H-A, Jiang C-J, Guo H-R. A study of insertional length of umbilical artery catheter in newborns. Chinese Journal of Pediatrics 30(2):100-104, Mar.-Apr. 1989.
  5. Chiang H-S, Guo H-R, Hong C-L, Lin S-M, Lee EF. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. British Journal of Urology 71(3):274-278, Mar. 1993.
  6. ChiangH-S, Guo H-R. Geographic distribution of high-risk areas for bladder cancer in blackfoot disease endemic area of Taiwan. Journal of Urology, R.O.C. 4(2):1079-1085, Jun. 1993.
  7. GuoH-R, Lu F-J. Re: "Arsenic ingestion and internal cancers: a review." American Journal of Epidemiology 139(12):1233-1234, Jun. 1994.
  8. Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and urinary cancers: a preliminary report. Environmental Geochemistry and Health 16(suppl.):119-128, 1994.
  9. GuoH-R, Chen C-J, Greene HL. Arsenic in drinking water and cancers: A descriptive review of Taiwan studies. Environmental Geochemistry and Health 16(suppl.):129-138, 1994.
  10. Guo H-R, Tanaka S, Cameron LL, Seligman PJ, Behrens VJ, Ger J, Wild DK, Putz-Anderson V. Back pain among workers in the United States: national estimates and workers at high risk. American Journal of Industrial Medicine 28(5):591-602, Nov. 1995.
  11. AbernathyCO, Chappell WR, Meek ME, Gibb H, Guo H-R. Is ingested inorganic arsenic a 'threshold' carcinogen? Fundamental and Applied Toxicology 29(2):168-175, Feb. 1996.
  12. Brown KG, Guo H-R, Kuo T-L, Greene HL. Skin cancer and inorganic arsenic: uncertainty-status of risk. Risk Analysis. 17(1):37-42, Feb. 1997.
  13. Chow N-H, Guo Y-L, Lin S-NJ, Su J-H, Tzai T-S, Guo H-R, Su I-J. Clinicopathologic features of bladder cancer associated with chronic exposure to arsenic. British Journal of Cancer 75(11):1708-1710, Jun. 1997.
  14. Brown KG, Guo H-R, Greene HL. Uncertainty in cancer risk at low doses of inorganic arsenic. Human and Ecological Risk Assessment 3(3):351-362, Jul. 1997.